Literature DB >> 31298796

Novel multicomponent organic-inorganic WPI/gelatin/CaP hydrogel composites for bone tissue engineering.

Michal Dziadek1,2,3, Radmila Kudlackova3,4, Aneta Zima2, Anna Slosarczyk2, Magdalena Ziabka2, Piotr Jelen5, Svetlana Shkarina6, Angelica Cecilia7, Marcus Zuber7,8, Tilo Baumbach7,8, Maria A Surmeneva6, Roman A Surmenev6, Lucie Bacakova4, Katarzyna Cholewa-Kowalska1, Timothy E L Douglas3,9.   

Abstract

The present work focuses on the development of novel multicomponent organic-inorganic hydrogel composites for bone tissue engineering. For the first time, combination of the organic components commonly used in food industry, namely whey protein isolate (WPI) and gelatin from bovine skin, as well as inorganic material commonly used as a major component of hydraulic bone cements, namely α-TCP in various concentrations (0-70 wt%) was proposed. The results showed that α-TCP underwent incomplete transformation to calcium-deficient hydroxyapatite (CDHA) during preparation process of the hydrogels. Microcomputer tomography showed inhomogeneous distribution of the calcium phosphate (CaP) phase in the resulting composites. Nevertheless, hydrogels containing 30-70 wt% α-TCP showed significantly improved mechanical properties. The values of Young's modulus and the stresses corresponding to compression of a sample by 50% increased almost linearly with increasing concentration of ceramic phase. Incomplete transformation of α-TCP to CDHA during preparation process of composites provides them high reactivity in simulated body fluid during 14-day incubation. Preliminary in vitro studies revealed that the WPI/gelatin/CaP composite hydrogels support the adhesion, spreading, and proliferation of human osteoblast-like MG-63 cells. The WPI/gelatin/CaP composite hydrogels obtained in this work showed great potential for the use in bone tissue engineering and regenerative medicine applications.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  calcium phosphate; gelatin; hydrogel composites; whey protein isolate

Year:  2019        PMID: 31298796     DOI: 10.1002/jbm.a.36754

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Rational design of hydrogels to enhance osteogenic potential.

Authors:  Soyon Kim; Min Lee
Journal:  Chem Mater       Date:  2020-11-05       Impact factor: 9.811

2.  WPI Hydrogels with a Prolonged Drug-Release Profile for Antimicrobial Therapy.

Authors:  Valentina O Plastun; Ekaterina S Prikhozhdenko; Olga I Gusliakova; Svetlana V Raikova; Timothy E L Douglas; Olga A Sindeeva; Oksana A Mayorova
Journal:  Pharmaceutics       Date:  2022-06-04       Impact factor: 6.525

3.  Composites Based on Hydroxyapatite and Whey Protein Isolate for Applications in Bone Regeneration.

Authors:  Dagmara Słota; Magdalena Głąb; Bożena Tyliszczak; Timothy E L Dogulas; Karolina Rudnicka; Krzysztof Miernik; Mateusz M Urbaniak; Paulina Rusek-Wala; Agnieszka Sobczak-Kupiec
Journal:  Materials (Basel)       Date:  2021-04-29       Impact factor: 3.623

4.  Marine-Inspired Enzymatic Mineralization of Dairy-Derived Whey Protein Isolate (WPI) Hydrogels for Bone Tissue Regeneration.

Authors:  Karl Norris; Magdalena Kocot; Anna M Tryba; Feng Chai; Abdullah Talari; Lorna Ashton; Bogdan V Parakhonskiy; Sangram K Samal; Nicholas Blanchemain; Elżbieta Pamuła; Timothy E L Douglas
Journal:  Mar Drugs       Date:  2020-06-02       Impact factor: 5.118

5.  Combining multi-scale 3D printing technologies to engineer reinforced hydrogel-ceramic interfaces.

Authors:  Paweena Diloksumpan; Mylène de Ruijter; Miguel Castilho; Uwe Gbureck; Tina Vermonden; P René van Weeren; Jos Malda; Riccardo Levato
Journal:  Biofabrication       Date:  2020-02-19       Impact factor: 9.954

6.  pH-Sensitive Dairy-Derived Hydrogels with a Prolonged Drug Release Profile for Cancer Treatment.

Authors:  Oksana A Mayorova; Ben C N Jolly; Roman A Verkhovskii; Valentina O Plastun; Olga A Sindeeva; Timothy E L Douglas
Journal:  Materials (Basel)       Date:  2021-02-05       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.